182 related articles for article (PubMed ID: 1378350)
1. Distribution of clusterin in Alzheimer brain tissue.
McGeer PL; Kawamata T; Walker DG
Brain Res; 1992 May; 579(2):337-41. PubMed ID: 1378350
[TBL] [Abstract][Full Text] [Related]
2. Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease.
Stoltzner SE; Grenfell TJ; Mori C; Wisniewski KE; Wisniewski TM; Selkoe DJ; Lemere CA
Am J Pathol; 2000 Feb; 156(2):489-99. PubMed ID: 10666378
[TBL] [Abstract][Full Text] [Related]
3. Expression of the complement membrane attack complex and its inhibitors in Pick disease brain.
Yasuhara O; Aimi Y; McGeer EG; McGeer PL
Brain Res; 1994 Aug; 652(2):346-9. PubMed ID: 7525023
[TBL] [Abstract][Full Text] [Related]
4. Association of apolipoprotein J-positive beta-amyloid plaques with dystrophic neurites in Alzheimer's disease brain.
Martin-Rehrmann MD; Hoe HS; Capuani EM; Rebeck GW
Neurotox Res; 2005; 7(3):231-42. PubMed ID: 15897157
[TBL] [Abstract][Full Text] [Related]
5. Possible neuroprotective role of clusterin in Alzheimer's disease: a quantitative immunocytochemical study.
Giannakopoulos P; Kövari E; French LE; Viard I; Hof PR; Bouras C
Acta Neuropathol; 1998 Apr; 95(4):387-94. PubMed ID: 9560017
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of beta-amyloid precursor protein sequences in Alzheimer and normal brain tissue by light and electron microscopy.
McGeer PL; Akiyama H; Kawamata T; Yamada T; Walker DG; Ishii T
J Neurosci Res; 1992 Mar; 31(3):428-42. PubMed ID: 1640495
[TBL] [Abstract][Full Text] [Related]
7. Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease.
Lidström AM; Bogdanovic N; Hesse C; Volkman I; Davidsson P; Blennow K
Exp Neurol; 1998 Dec; 154(2):511-21. PubMed ID: 9878186
[TBL] [Abstract][Full Text] [Related]
8. Relationship between multifunctional protein "clusterin" and Alzheimer disease.
Choi-Miura NH; Oda T
Neurobiol Aging; 1996; 17(5):717-22. PubMed ID: 8892344
[TBL] [Abstract][Full Text] [Related]
9. Pathological proteins in senile plaques.
McGeer PL; Klegeris A; Walker DG; Yasuhara O; McGeer EG
Tohoku J Exp Med; 1994 Nov; 174(3):269-77. PubMed ID: 7761992
[TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of brain clusterin.
Oda T; Pasinetti GM; Osterburg HH; Anderson C; Johnson SA; Finch CE
Biochem Biophys Res Commun; 1994 Nov; 204(3):1131-6. PubMed ID: 7980587
[TBL] [Abstract][Full Text] [Related]
11. Perforant path transection induces complement C9 deposition in hippocampus.
Johnson Sa; Young-Chan CS; Laping NJ; Finch CE
Exp Neurol; 1996 Apr; 138(2):198-205. PubMed ID: 8620918
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein J (clusterin) and Alzheimer's disease.
Calero M; Rostagno A; Matsubara E; Zlokovic B; Frangione B; Ghiso J
Microsc Res Tech; 2000 Aug; 50(4):305-15. PubMed ID: 10936885
[TBL] [Abstract][Full Text] [Related]
13. Expression of the membrane attack complex of complement and its inhibitors during human liver allograft transplantation.
Conti F; Grude P; Calmus Y; Scoazec JY
J Hepatol; 1997 Nov; 27(5):881-9. PubMed ID: 9382976
[TBL] [Abstract][Full Text] [Related]
14. Clusterin solubility and aggregation in Creutzfeldt-Jakob disease.
Freixes M; Puig B; Rodríguez A; Torrejón-Escribano B; Blanco R; Ferrer I
Acta Neuropathol; 2004 Oct; 108(4):295-301. PubMed ID: 15235804
[TBL] [Abstract][Full Text] [Related]
15. Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress.
Oda T; Wals P; Osterburg HH; Johnson SA; Pasinetti GM; Morgan TE; Rozovsky I; Stine WB; Snyder SW; Holzman TF
Exp Neurol; 1995 Nov; 136(1):22-31. PubMed ID: 7589331
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical localization of vitronectin, its receptor and beta-3 integrin in Alzheimer brain tissue.
Akiyama H; Kawamata T; Dedhar S; McGeer PL
J Neuroimmunol; 1991 Apr; 32(1):19-28. PubMed ID: 1705945
[TBL] [Abstract][Full Text] [Related]
17. Clusterin in renal tissue: preferential localization with the terminal complement complex and immunoglobulin deposits in glomeruli.
French LE; Tschopp J; Schifferli JA
Clin Exp Immunol; 1992 Jun; 88(3):389-93. PubMed ID: 1606720
[TBL] [Abstract][Full Text] [Related]
18. Lactotransferrin immunocytochemistry in Alzheimer and normal human brain.
Kawamata T; Tooyama I; Yamada T; Walker DG; McGeer PL
Am J Pathol; 1993 May; 142(5):1574-85. PubMed ID: 8494052
[TBL] [Abstract][Full Text] [Related]
19. Neuropathological characterization of mutant amyloid precursor protein yeast artificial chromosome transgenic mice.
Kulnane LS; Lamb BT
Neurobiol Dis; 2001 Dec; 8(6):982-92. PubMed ID: 11741394
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease.
McGeer PL; Rogers J
Neurology; 1992 Feb; 42(2):447-9. PubMed ID: 1736183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
